Home » Stocks » TFF Pharmaceuticals

TFF Pharmaceuticals, Inc. (TFFP)

Stock Price: $6.44 USD 0.25 (4.04%)
Updated Jul 10, 2020 4:00 PM EDT - Market closed

Stock Price Chart

Key Info

Market Cap 120.25M
Revenue (ttm) n/a
Net Income (ttm) n/a
Shares Out 18.67M
EPS (ttm) -2.60
PE Ratio n/a
Forward PE n/a
Dividend n/a
Dividend Yield n/a

Stock Quote

Trading Day Jul 10, 2020
Last Price $6.44
Previous Close $6.19
Change ($) 0.25
Change (%) 4.04%
Day's Open 6.23
Day's Range 6.00 - 6.48
Day's Volume 103,468
52-Week Range 3.44 - 6.92

More Stats

Market Cap 120.25M
Enterprise Value 94.52M
Earnings Date (est) n/a
Ex-Dividend Date n/a
Shares Outstanding 18.67M
Float 11.79M
EPS (basic) n/a
EPS (diluted) -2.60
FCF / Share n/a
Dividend n/a
Dividend Yield n/a
Earnings Yield n/a
FCF Yield n/a
Payout Ratio n/a
Shares Short 50,200
Short Ratio 0.47
Short % of Float 0.38%
Beta n/a
PE Ratio n/a
Forward PE n/a
P/FCF Ratio n/a
PS Ratio n/a
PB Ratio 4.71
Revenue n/a
Operating Income n/a
Net Income n/a
Free Cash Flow n/a
Net Cash 25.73M
Net Cash / Share 1.38
Gross Margin n/a
Operating Margin n/a
Profit Margin n/a
FCF Margin n/a
ROA -48.83%
ROE -83.38%
ROIC n/a
Stats based on trailing-twelve-month (ttm) numbers.

Analyst Summary

Analyst Ratings (2)

Buy 2
Overweight 0
Hold 0
Underweight 0
Sell 0

Analyst Consensus: Buy

Price Target

(109.63% upside)
Current: 6.44
Target: 13.50
*Average 12-month price target from 2 stock analysts.

Financial Performance

Financial numbers in millions USD.

Financial Overview

Operating Income-11.99-3.90-0.18
Net Income-11.87-3.84-0.18
Shares Outstanding6.903.48-
Earnings Per Share-5.31-1.31-
Operating Cash Flow-11.22-2.13-0.19
Free Cash Flow-11.22-2.13-0.19
Cash & Equivalents28.0910.260.00
Net Cash / Debt28.0910.260.00
Book Value27.64-3.24-
Numbers in millions USD, except per-share numbers.

Company Profile

Company Details

Full Name TFF Pharmaceuticals, Inc.
Country United States
Employees 4
CEO Glenn R. Mattes

Stock Information

Ticker Symbol TFFP
Stock Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Unique Identifier NASDAQ: TFFP


TFF Pharmaceuticals, Inc., an early-stage biopharmaceutical company, focuses on developing and commercializing drug products based on its patented Thin Film Freezing, or TFF, technology platform. It intends to initially focus on the development of inhaled dry powder drugs for the treatment of pulmonary diseases and conditions. The company has a research collaboration with the University of Georgia's Center for Vaccines and Immunology (CVI), along with the University of Texas at Austin (UT Austin), to evaluate the immunogenicity of universal influenza vaccines; and cooperative research and development agreement with United States Army Medical Research Institute of Infectious Diseases for use of its thin film freezing technology platform. TFF Pharmaceuticals, Inc. was founded in 2018 and is based in Austin, Texas.